SHE · Healthcare

Hualan Biological Bacterin Inc. (301207)

Biotechnology

Hualan Biological Bacterin Inc. (301207) is listed on SHE in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $11.52B, P/E ratio is 159.75, net margin is 7.2%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for 301207

Market cap
$11.52B
P/E ratio
159.75
Gross profit (TTM)
$685.60M
Net margin
7.2%

Hualan Biological Bacterin Inc. (301207) — FAQ

What is Hualan Biological Bacterin Inc.'s market cap?

Hualan Biological Bacterin Inc. (301207) has a reported market cap of $11.52B (data as of 2026-03-29).

What is 301207's P/E ratio?

The price-to-earnings (P/E) ratio for Hualan Biological Bacterin Inc. (301207) is 159.75 (data as of 2026-03-29).

Does Hualan Biological Bacterin Inc. pay a dividend?

Dividend yield is not available in the current snapshot for Hualan Biological Bacterin Inc. (301207). Check the MyAverix Finance app for the latest dividend data.

What sector is Hualan Biological Bacterin Inc. in?

Hualan Biological Bacterin Inc. (301207) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 301207 listed on?

301207 is listed on SHE.

What is Hualan Biological Bacterin Inc.'s net margin?

Hualan Biological Bacterin Inc. (301207) reports a net margin of 7.2% (data as of 2026-03-29).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play